iCAD
✓ Verified
Healthcare AI
Cancer detection and breast imaging AI
Acquired
iCAD, Inc. is a medical technology company focused on AI-powered cancer detection and breast health solutions, including the ProFound Breast Health Suite for mammography analysis, breast density assessment, and risk evaluation. The company has marketed AI-based detection products across breast, prostate, and colorectal imaging and operated as a public company headquartered in Nashua, New Hampshire, until its acquisition by RadNet/DeepHealth was announced in 2025.
Company Details
- Website
- icadmed.com
- Headquarters
- Nashua, New Hampshire, United States
- Founded
- 1984
- Funding
- Undisclosed
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring